Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

83 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Guillain-Barré syndrome after viral hepatitis A.
López Ruiz R, Dotor García-Soto J, Eichau S. López Ruiz R, et al. Among authors: eichau s. Med Clin (Barc). 2020 Mar 27;154(6):238-239. doi: 10.1016/j.medcli.2019.02.005. Epub 2019 Apr 7. Med Clin (Barc). 2020. PMID: 30971337 English, Spanish. No abstract available.
[Systemic toxicity secondary to local anesthetic infiltration].
López-Ruiz R, Guerra-Hiraldo JD, Dotor-García Soto J, Sánchez-Fernández F, Ruiz-de Arcos M, Eichau S. López-Ruiz R, et al. Among authors: eichau s. Rev Neurol. 2022 Sep 1;75(5):123-125. doi: 10.33588/rn.7505.2021280. Rev Neurol. 2022. PMID: 35880966 Free PMC article. Spanish.
Skin Autoimmunity Secondary to Alemtuzumab in a Tertiary Care Spanish Hospital.
López Ruiz R, Sánchez Fernández F, Ruiz de Arcos M, Dotor García-Soto J, Fuerte Hortigón A, Navarro Mascarell G, Ruiz Peña JL, Páramo Camino MD, Guerra Hiraldo JD, Eichau S. López Ruiz R, et al. Among authors: eichau s. Neurol Clin Pract. 2022 Feb;12(1):29-35. doi: 10.1212/CPJ.0000000000001126. Neurol Clin Pract. 2022. PMID: 36157628 Free PMC article.
Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
Lefort M, Sharmin S, Andersen JB, Vukusic S, Casey R, Debouverie M, Edan G, Ciron J, Ruet A, De Sèze J, Maillart E, Zephir H, Labauge P, Defer G, Lebrun-Frenay C, Moreau T, Berger E, Clavelou P, Pelletier J, Stankoff B, Gout O, Thouvenot E, Heinzlef O, Al-Khedr A, Bourre B, Casez O, Cabre P, Montcuquet A, Wahab A, Camdessanché JP, Maurousset A, Ben Nasr H, Hankiewicz K, Pottier C, Maubeuge N, Dimitri-Boulos D, Nifle C, Laplaud DA, Horakova D, Havrdova EK, Alroughani R, Izquierdo G, Eichau S, Ozakbas S, Patti F, Onofrj M, Lugaresi A, Terzi M, Grammond P, Grand'Maison F, Yamout B, Prat A, Girard M, Duquette P, Boz C, Trojano M, McCombe P, Slee M, Lechner-Scott J, Turkoglu R, Sola P, Ferraro D, Granella F, Shaygannejad V, Prevost J, Maimone D, Skibina O, Buzzard K, Van der Walt A, Karabudak R, Van Wijmeersch B, Csepany T, Spitaleri D, Vucic S, Koch-Henriksen N, Sellebjerg F, Soerensen PS, Hilt Christensen CC, Rasmussen PV, Jensen MB, Frederiksen JL, Bramow S, Mathiesen HK, Schreiber KI, Butzkueven H, Magyari M, Kalincik T, Leray E. Lefort M, et al. Among authors: eichau s. BMC Med Res Methodol. 2022 May 30;22(1):155. doi: 10.1186/s12874-022-01623-8. BMC Med Res Methodol. 2022. PMID: 35637426 Free PMC article.
83 results